-
By Janet Levaux, AdvisorOne |
March 25, 2010
Also, the U.S. Attorney's office in New York filed criminal charges against Igor Poteroba, a healthcare banker in the Swiss bank's New York office, and his friend, Aleksey Koval.
-
By Janet Levaux, AdvisorOne |
March 1, 2010
Damien Conover, CFA Karen Andersen, CFA Morningstar 312-696-6000 Pharmaceuticals: While the majority of pharmaceutical companies are losing patents on major blockbuster drugs over the next five years, strong pipelines...
-
By Kenneth Silber, Research |
October 1, 2009
Biotech has long been a high-risk, high-reward industry. It is an industry in which numerous firms, including many small-caps and start-ups, intensively research possible...
-
By Janet Levaux, AdvisorOne |
September 1, 2009
Research's Health Care Guide: Beckman Coulter Inc. (BEC) Roche Holding AG (RHHBY) Watson Pharmaceuticals Inc. (WPI) --- Karen Andersen,...
-
By Stan Luxenburg |
March 1, 2009
During 2008, health funds lost 23.3%, according to Morningstar. While shareholders may have seen little reason to cheer, the group did outdo the S&P 500...
-
By Janet Levaux, AdvisorOne |
September 1, 2008
Thanks to new drugs, acquisitions and other factors, biotech and health-care firms alike are forging beneficial growth and development strategies - which is good news...
-
By Staff Writer |
May 1, 2008
According to redOrbit.com, a new "brain fitness" software industry is emerging as aging baby boomers seek to keep not only their bodies, but their minds...
-
By Janet Levaux, AdvisorOne |
March 1, 2008
Stocks in health care, including biotech and pharmaceuticals, are poised for higher levels in 2008 - thanks to present valuations, developing pipelines and acquisition horizons,...
-
By Staff Writer |
December 4, 2007
Medical device and pharmaceutical companies are seizing the opportunity to help hospitals with infection control. While interest in infection control isn't new, hospitals are under greater pressure to control HAIs, as bacteria become more resistant to existing therapies and payers tally the mounting costs of treatment for complications that might...
-
By Staff Writer |
December 1, 2007
A select group of market segments and companies are poised to improve results in the coming months, analysts say. --- Analyst: Ronald A. Tadross, CFAFirm: Banc of...